Helland, Thomas <br/><br/>
Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database.  [electronic resource] 

 -  Breast cancer research and treatment  Aug 2019 
 - 185-195 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-019-05294-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Biomarkers<br/>Breast Neoplasms--complications<br/>Chromatography, Liquid<br/>Drug Monitoring<br/>Female<br/>Humans<br/>Medication Adherence<br/>Middle Aged<br/>Patient Reported Outcome Measures<br/>Prognosis<br/>Surveys and Questionnaires<br/>Tamoxifen--adverse effects<br/>Tandem Mass Spectrometry<br/>Vagina--drug effects<br/>Young Adult